Chemoinformaics analysis of 4,10-Dihydroxy-2-oxo-1(5)-guaien-12,6-olide
| Molecular Weight | 320.341 | nRot | 3 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 20 |
| Exact Molecular Weight | 320.126 | nRing | 2 |
| Solubility: LogS | -2.277 | nHRing | 1 |
| Solubility: LogP | 0.584 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 46.5379 |
| nHD | 1 | BPOL | 26.1401 |
| QED | 0.451 |
| Synth | 5.047 |
| Natural Product Likeliness | 3.514 |
| NR-PPAR-gamma | 0.208 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.481 |
| CACO-2 | -5.05 |
| MDCK | 0.000132954 |
| BBB | 0.86 |
| PPB | 0.565423 |
| VDSS | 0.742 |
| FU | 0.444254 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.082 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.07 |
| CYP2c9-inh | 0.033 |
| CYP2c9-sub | 0.065 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.116 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.224 |
| CL | 11.33 |
| T12 | 0.321 |
| hERG | 0.007 |
| Ames | 0.012 |
| ROA | 0.942 |
| SkinSen | 0.155 |
| Carcinogencity | 0.544 |
| EI | 0.065 |
| Respiratory | 0.865 |
| NR-Aromatase | 0.12 |
| Antiviral | Yes |
| Prediction | 0.878073 |